D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Alibaba
BABA
|
+$655M |
| 2 |
NVIDIA
NVDA
|
+$579M |
| 3 |
Amazon
AMZN
|
+$425M |
| 4 |
ConocoPhillips
COP
|
+$423M |
| 5 |
Johnson & Johnson
JNJ
|
+$380M |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$868M |
| 2 |
Meta Platforms (Facebook)
META
|
+$554M |
| 3 |
Apple
AAPL
|
+$461M |
| 4 |
CELG
Celgene Corp
CELG
|
+$339M |
| 5 |
Pfizer
PFE
|
+$316M |
Sector Composition
| 1 | Technology | 19.2% |
| 2 | Consumer Discretionary | 16.83% |
| 3 | Healthcare | 16.01% |
| 4 | Industrials | 8.99% |
| 5 | Financials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLNT
1826
Fluent
FLNT
$49.3M
| $1.04M | ﹤0.01% |
32,158
-43,705
| -58% | -$1.41M |
|
1827
Safe Bulkers
SB
$458M
| $1.04M | ﹤0.01% |
664,886
+23,117
| +4% | +$36.1K |
|
1828
Bristow Group
VTOL
$1.1B
| $1.04M | ﹤0.01% |
62,231
-9,607
| -13% | -$160K |
|
1829
Xerox
XRX
$466M
| $1.04M | ﹤0.01% |
29,312
+7,400
| +34% | +$262K |
|
1830
Rockwell Medical
RMTI
$58.2M
| $1.04M | ﹤0.01% |
31,265
+1,972
| +7% | +$65.3K |
|
1831
CorVel
CRVL
$4.53B
| $1.03M | ﹤0.01% |
35,583
+10,638
| +43% | +$309K |
|
1832
Glacier Bancorp
GBCI
$5.8B
| $1.02M | ﹤0.01% |
25,105
+7,552
| +43% | +$306K |
|
1833
Seres Therapeutics
MCRB
$154M
| $1.02M | ﹤0.01% |
15,791
+1,526
| +11% | +$98.3K |
|
1834
Myers Industries
MYE
$612M
| $1.02M | ﹤0.01% |
52,652
+10,164
| +24% | +$196K |
|
|
VEDL
1835
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $1.01M | ﹤0.01% |
+99,144
| New | +$1.01M |
|
|
MITT
1836
AG Mortgage Investment Trust
MITT
$247M
| $1.01M | ﹤0.01% |
21,102
+15,326
| +265% | +$731K |
|
1837
Tanger
SKT
$3.91B
| $1.01M | ﹤0.01% |
+62,048
| New | +$1.01M |
|
1838
Applied Industrial Technologies
AIT
$10.2B
| $1M | ﹤0.01% |
16,266
-8,871
| -35% | -$546K |
|
|
CRZO
1839
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $1M | ﹤0.01% |
99,931
+69,382
| +227% | +$695K |
|
|
FCRD
1840
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $1M | ﹤0.01% |
150,616
-50,321
| -25% | -$334K |
|
1841
Alnylam Pharmaceuticals
ALNY
$61.4B
| $998K | ﹤0.01% |
13,757
+2,543
| +23% | +$184K |
|
1842
Dillards
DDS
$9.15B
| $993K | ﹤0.01% |
15,948
-192,322
| -92% | -$12M |
|
1843
DaVita
DVA
$9.53B
| $991K | ﹤0.01% |
17,618
-213,356
| -92% | -$12M |
|
1844
Fortuna Silver Mines
FSM
$2.59B
| $991K | ﹤0.01% |
347,699
-208,100
| -37% | -$593K |
|
1845
Home BancShares
HOMB
$5.79B
| $991K | ﹤0.01% |
51,475
-9,639
| -16% | -$186K |
|
1846
Mersana Therapeutics
MRSN
$37.3M
| $991K | ﹤0.01% |
9,793
+5,209
| +114% | +$527K |
|
1847
OceanFirst Financial
OCFC
$1.05B
| $984K | ﹤0.01% |
+39,599
| New | +$984K |
|
1848
Zebra Technologies
ZBRA
$16.1B
| $979K | ﹤0.01% |
4,673
-23,500
| -83% | -$4.92M |
|
1849
Artisan Partners
APAM
$3.32B
| $970K | ﹤0.01% |
+35,240
| New | +$970K |
|
1850
Federated Hermes
FHI
$4.2B
| $967K | ﹤0.01% |
29,742
+22,309
| +300% | +$725K |
|